Actively Recruiting
The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study
Led by Shanghai Zhongshan Hospital · Updated on 2023-08-01
10000
Participants Needed
1
Research Sites
630 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of the China Monoclonal Gammopathy Screening Project in First-degree Relatives of Patients With Multiple Myeloma (CHAPERONE) study is to assess the clinical significance of screening for monoclonal gammopathy (M-protein) in first-degree relatives of patients with multiple myeloma in China population, and establish a prospective cohort of individuals with monoclonal gammopathy of undetermined significance (MGUS), a precursor conditions to multiple myeloma. We will study these patients as a means to identify risk factors for progression to symptomatic multiple myeloma.
CONDITIONS
Official Title
The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female over the age of 18
- First-degree relatives (parents, children, or biological siblings) of patients diagnosed with multiple myeloma
- Understand the study purpose and procedures and voluntarily agree to participate
- Willing and able to follow the study's follow-up plan and protocol requirements
You will not qualify if you...
- Known diagnosis of plasma cell diseases, including MGUS, smoldering myeloma, or multiple myeloma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Hospital，Fudan University
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
P
Peng Liu, PhD, MD
CONTACT
J
Jing Li, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here